Betsy Flaherty
@Portolan Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$1.38BTotal holdings129
Assets growth rate13.6%Assets growth rate (2-Q avg)3.05%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Portolan Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 129 positions.
Assets under management
The assets under management (AUM) of Portolan Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.38B in assets, with a quarterly growth rate of 13.6% and a 2-quarter average growth rate of 3.05%. The portfolio is managed by Betsy Flaherty, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MGPIMgp Ingredients Inc New
| 0.5% | $6.777M 81,400 shares@ $83.25 avg price | New Position |
MTCHMatch Group Inc New
| 0.48% | $6.562M 173,414 shares@ $37.85 avg price | New Position |
CORZCore Scientific Inc New
| 0.48% | $6.546M 551,977 shares@ $11.86 avg price | New Position |
HCATHealth Catalyst Inc
| 0.4% | $5.402M 663,602 shares@ $8.14 avg price | New Position |
DOUGDouglas Elliman Inc
| 0.39% | $5.327M 2.911M shares@ $1.84 avg price | New Position |
RHRh
| 0.38% | $5.177M 15,480 shares@ $334.43 avg price | New Position |
TXNMTxnm Energy Inc
| 0.37% | $5.049M 115,360 shares@ $43.77 avg price | New Position |
EBAYEbay Inc.
| 0.37% | $4.998M 76,760 shares@ $65.12 avg price | New Position |
MYGNMyriad Genetics Inc
| 0.36% | $4.92M 179,634 shares@ $27.39 avg price | New Position |
RPRXRoyalty Pharma Plc
| 0.35% | $4.822M 170,464 shares@ $28.3 avg price | New Position |